These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10876868)
1. [A killed commercial vaccine against herpes simplex viruses 1 and 2 as an immunocorrective agent in chronic herpetic infection]. Barinskiĭ IF; Kasparov AA; Lazarenko AA; Alimbarova LM; Davydova AA; Belkina IV; Platonova AL Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):98-102. PubMed ID: 10876868 [No Abstract] [Full Text] [Related]
2. Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection. Mastrolorenzo A; Tiradritti L; Salimbeni L; Zuccati G Int J STD AIDS; 1995; 6(6):431-5. PubMed ID: 8845402 [TBL] [Abstract][Full Text] [Related]
3. Development of prophylactic vaccines for genital and neonatal herpes. Jones CA; Cunningham AL Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338 [TBL] [Abstract][Full Text] [Related]
4. Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology. Sandgren KJ; Truong NR; Smith JB; Bertram K; Cunningham AL Methods Mol Biol; 2020; 2060():31-56. PubMed ID: 31617171 [TBL] [Abstract][Full Text] [Related]
14. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Da Costa XJ; Morrison LA; Knipe DM Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897 [TBL] [Abstract][Full Text] [Related]
15. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease. Jones CA; Cunningham AL Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632 [TBL] [Abstract][Full Text] [Related]
16. New concepts in herpes simplex virus vaccine development: notes from the battlefield. Dasgupta G; Chentoufi AA; Nesburn AB; Wechsler SL; BenMohamed L Expert Rev Vaccines; 2009 Aug; 8(8):1023-35. PubMed ID: 19627185 [TBL] [Abstract][Full Text] [Related]
17. A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice. Fleck M; Podlech J; Weise K; Falke D Med Microbiol Immunol; 1994 May; 183(2):87-94. PubMed ID: 7935163 [TBL] [Abstract][Full Text] [Related]
18. A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. Boursnell ME; Entwisle C; Blakeley D; Roberts C; Duncan IA; Chisholm SE; Martin GM; Jennings R; Ni Challanaín D; Sobek I; Inglis SC; McLean CS J Infect Dis; 1997 Jan; 175(1):16-25. PubMed ID: 8985191 [TBL] [Abstract][Full Text] [Related]
19. Developments in herpes simplex virus vaccines: old problems and new challenges. Rajcáni J; Durmanová V Folia Microbiol (Praha); 2006; 51(2):67-85. PubMed ID: 16821715 [TBL] [Abstract][Full Text] [Related]
20. Genital herpes vaccines--cause for cautious optimism. Haddow LJ; Mindel A Sex Health; 2006 Mar; 3(1):1-4. PubMed ID: 16607967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]